worldwid
panic
chao
result
outbreak
sever
acut
respiratori
syndrom
sar
februari
caus
novel
coronaviru
sarscov
unpreced
twentyfirst
centuri
sar
rapidli
spread
via
hong
kong
rest
asia
north
america
europ
within
month
affect
patient
mortal
rate
may
sar
declar
erad
world
health
organ
thu
becom
second
human
diseas
smallpox
receiv
label
coronavirus
isol
civet
cat
game
anim
china
remark
sequenc
homolog
sarscov
suggest
zoonot
origin
three
nondistinct
theoret
phase
sar
name
viral
replic
inflammatori
pneumon
pulmonari
fibrosi
shed
sarscov
evalu
reversetranscriptas
rt
pcr
peak
day
onset
fever
nasopharyng
aspir
fece
respect
autopsi
studi
sar
lung
reveal
nonspecif
featur
includ
diffus
alveolar
damag
secondari
bacteri
pneumonia
giant
cell
macrophag
infiltr
alveoli
lung
interstitium
nichol
et
al
presenc
subpleur
fibrogranul
prolifer
small
airway
air
space
similar
bronchiol
obliteran
organ
pneumonia
steroidrespons
immunemedi
pneumon
four
sar
patient
pulmonari
thromboemboli
otherwis
unusu
condit
among
asian
sarscov
appear
spread
mainli
droplet
transmiss
although
fomit
fece
also
possibl
mode
human
transmiss
airborn
transmiss
might
contribut
outbreak
amoy
garden
residenti
complex
hong
kong
hundr
peopl
infect
mean
incub
period
sar
day
day
clinic
featur
summar
tabl
key
featur
occurr
rapidli
progress
pneumonia
sometim
dramat
overnight
progress
mild
bilater
pneumonia
acut
respiratori
distress
syndrom
occurr
upper
respiratori
tract
symptom
unusu
patient
diarrhea
could
potenti
highli
infecti
physic
sign
scarc
first
day
becom
promin
patient
develop
extens
lung
consolid
although
sar
predominantli
respiratori
ill
extrapulmonari
manifest
infrequ
encount
tabl
fever
onset
sar
patient
airspac
consolid
especi
peripher
lower
zone
distribut
chest
radiograph
tsang
et
al
gener
rapid
deterior
groundglass
consolid
occur
first
day
peak
day
onset
fever
becom
multilobar
bilater
figur
pneumomediastinum
pneumothorac
often
spontan
also
occur
assist
ventil
complic
extens
diseas
figur
current
diagnosi
sar
entail
demonstr
clinic
featur
fever
c
respiratori
symptom
radiograph
pneumonia
autopsi
result
consist
patholog
otherwis
unexplain
ill
presenc
virolog
proof
sarscov
infect
ie
posit
rtpcr
presenc
sarscov
rna
seroconvers
signific
antibodi
rise
pair
sera
viru
isol
practic
prerequisit
diagnosi
sar
includ
presenc
epidemiolog
linkag
rapidli
progress
pneumonia
resist
standard
treatment
clinic
featur
virolog
evid
sarscov
infect
epidemiolog
link
defin
histori
contact
sar
patient
visit
hospit
nosocomi
sar
outbreak
day
preced
diseas
onset
use
even
patient
area
outbreak
virtual
patient
deterior
despit
potent
antibiot
therapi
lymphopenia
rais
transaminas
level
treatment
sar
administ
amid
crisi
situat
larg
anecdot
without
back
control
trial
data
theoret
none
manifest
sar
would
occur
efficaci
antivir
agent
given
diseas
onset
howev
agent
proven
efficaci
avail
despit
prolif
suggest
apart
administ
empir
antibiot
therapi
sever
communityacquir
pneumonia
control
clinic
trial
conduct
evalu
efficaci
potenti
antivir
immunomodul
agent
clinic
experi
avail
agent
use
outbreak
name
ribavirin
ritonavirlopinavir
interferon
corticosteroid
immunoglobulin
convalesc
serum
histor
sar
even
defin
patient
treat
broadspectrum
antivir
agent
name
ribavirin
corticosteroid
patient
drop
hemoglobin
gdl
treatment
ribavirin
g
tid
two
week
higher
dose
associ
elev
liver
transaminas
level
bradycardia
booth
et
al
rapid
recoveri
first
hong
kong
patient
led
adopt
standard
antisar
regimen
hong
kong
elsewher
ribavirin
consid
ineffect
efficaci
possibl
antisarscov
agent
antiproteas
like
kaletra
ritonavir
mg
lopinavir
mg
day
combin
ribavirin
initi
treatment
associ
reduct
mortal
vs
intub
rate
vs
compar
histor
control
chu
et
al
appear
therefor
ritonavirlopinavir
could
consid
earli
treatment
sar
patient
prefer
control
clinic
trial
set
advers
reaction
infrequ
includ
sever
pancreat
diarrhea
abdomin
pain
asthenia
headach
nausea
insomnia
skin
rash
interferon
human
leukocyt
interferon
exhibit
complet
inhibit
cytopath
effect
sarscov
vitro
sar
patient
treat
corticosteroid
interferon
less
icu
admiss
mechan
ventil
death
counterpart
loutfi
et
al
sarscov
envelop
rna
viru
contain
sever
structur
protein
current
differ
vaccin
whole
kill
vaccin
adenoviru
vector
vaccin
recombin
spike
protein
vaccin
test
among
laboratori
anim
none
readi
largescal
clinic
trial
administr
corticosteroid
deterior
sar
patient
associ
signific
sometim
dramat
radiograph
clinic
recoveri
figur
despit
skeptic
immunomodul
drug
could
consid
rescu
therapi
patient
puls
steroid
therapi
eg
methylprednisolon
mg
daili
day
higher
cumul
steroid
dosag
side
effect
less
oxygen
requir
better
radiograph
outcom
counterpart
although
retrospect
analysi
show
higher
mortal
among
patient
puls
methylprednisolon
could
due
higher
likelihood
use
therapi
sever
sar
case
corticosteroid
effect
antiinflammatori
agent
significantli
reduc
monocyt
chemoattract
ifng
induc
level
sar
use
highdos
steroid
associ
sepsi
particularli
ventilatorassoci
pneumonia
even
system
fungal
infect
approxim
sar
patient
mriproven
avascular
necrosi
avn
hip
knee
griffith
et
al
could
steroidinduc
incid
seem
much
higher
among
recipi
organ
transplant
despit
similar
steroid
dosag
intraven
gammaglobulin
ivig
may
downregul
cytokin
express
sar
howev
ill
patient
receiv
ivig
develop
pulmonari
embol
larg
arteri
ischem
stroke
despit
prophylact
lowmolecularweight
heparin
treatment
pentaglobin
commerci
avail
igmenrich
ivig
theoret
enhanc
immunomodul
effect
associ
improv
oxygen
radiograph
score
convalesc
serum
administ
hong
kong
sar
patient
recipi
shorter
hospit
stay
lower
mortal
counterpart
soo
et
al
possibl
transmiss
sarscov
pathogen
theoret
disadvantag
proinflammatori
action
current
unavail
make
mode
potenti
therapi
unaccept
numer
agent
propos
potenti
efficaci
sar
virtu
vitro
mere
theoret
activ
sarscov
includ
glycyrrhizin
licoric
extract
synthet
rna
duplex
target
sarscov
genom
nelfinavir
aminopeptidas
n
inhibitor
niclosamid
rhinoviru
proinhibitor
analog
antitumor
necrosi
factora
heparin
antiplatelet
agent
sodium
nitroprussid
monoclon
antibodi
protein
tsang
et
al
sar
patient
develop
acut
respiratori
distress
syndrom
requir
invas
mechan
ventil
associ
nosocomi
spread
sar
howev
nippv
usag
among
hong
kong
sar
patient
found
effect
oxygen
prevent
intub
evid
nosocomi
spread
sar
cheung
et
al
averag
hospit
durat
day
hong
kong
patient
mortal
final
case
fatal
ratio
hong
kong
canada
due
much
higher
mortal
among
poorer
prognosi
poor
prognost
factor
predict
icu
admiss
death
includ
advanc
age
chronic
hepat
b
treat
lamivudin
diabet
mellitu
comorbid
condit
high
serum
lactat
dehydrogenas
high
neutrophil
count
low
lymphocyt
count
rehabilit
sar
patient
exhibit
high
incid
moodand
stressrel
disord
recurr
sar
among
survivor
report
import
control
sar
ensur
outbreak
within
hospit
well
commun
detail
measur
would
beyond
scope
articl
briefli
patient
isol
promptli
ensur
spread
sarscov
fellow
patient
staff
isol
nurs
could
achiev
dedic
singl
room
open
ward
long
close
supervis
maintain
air
exchang
rate
time
per
hour
temperatur
c
appear
desir
wear
person
protect
equip
ppe
staff
could
warm
time
person
protect
equip
provid
train
staff
includ
use
fullbodi
gown
highspecif
mask
mask
staff
requir
follow
strict
stepwis
gown
degown
procedur
strict
person
hygien
common
sens
import
dilut
bleach
use
wipe
work
surfac
floor
everi
hour
potenti
contamin
nebul
therapi
alleg
caus
major
hospit
outbreak
hong
kong
mode
therapi
forbidden
patient
suspect
probabl
sar
hong
kong
see
also
quarantin
histori
